Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.8.0.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Income Statement [Abstract]      
Grant revenues $ 78
Operating expenses      
Research and development 5,822 101,679 47,261
General and administrative 2,440 4,140 6,765
Total operating expenses 8,262 105,819 54,026
Loss from operations (8,262) (105,819) (53,948)
Interest income (expense), net (7) 126 180
Other expense (131) (1)
Loss on return of escrowed shares (1,686)
Impairment on mortgage note receivable (1,177)
Change in fair value of derivative liabilities 907 2,603 (9,916)
Total other income (expense), net 769 1,551 (11,422)
Loss before income taxes (7,493) (104,268) (65,370)
Income tax benefit 6,880 29,394 15,248
Net loss $ (613) $ (74,874) $ (50,122)
Net loss per common share:      
Net loss per share, basic $ (0.03) $ (3.18) $ (2.40)
Net loss per share, diluted $ (0.03) $ (3.30) $ (2.40)
Weighted average common shares outstanding, basic 24,126,000 23,518,000 21,011,000
Weighted average common shares outstanding, diluted 24,126,000 23,533,000 21,011,000